Intravenous Iron Drugs Market Size, Share, Demand & Trends Analysis Report by 2032

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Intravenous Iron Drugs Market, 2016–2025 (USD Million)
  • 2.2. Intravenous Iron Drugs Market: Snapshot
• Chapter 3. Intravenous Iron Drugs Market – Industry Analysis
  • 3.1. Intravenous Iron Drugs Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Increasing incidence of chronic renal disease
    • 3.2.2. Increasing geriatric population
  • 3.3. Restraints
    • 3.3.1. Some side-effects associated with intravenous iron drugs
    • 3.3.2. Stringent regulations
  • 3.4. Opportunities
    • 3.4.1. Development of novel products
    • 3.4.2. Growing need for prevention of anemia in pregnant women
  • 3.5. Porter’s Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis By Product
    • 3.6.2. Market attractiveness analysis By Application
    • 3.6.3. Market attractiveness analysis by Region
• Chapter 4. Intravenous Iron Drugs Market– Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Intravenous Iron Drugs Market: company market share, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Product launches
    • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Intravenous Iron Drugs Market –Product Analysis
  • 5.1. Global Intravenous Iron Drugs Market overview: By Product
    • 5.1.1. Global Intravenous Iron Drugs Market share, By Product,2018 and 2025
  • 5.2. Ferric Carboxymaltose
    • 5.2.1. Global Intravenous Iron Drugs Market by Ferric Carboxymaltose, 2016–2025 (USD Million)
  • 5.3. Iron Sucrose
    • 5.3.1. Global Intravenous Iron Drugs Market by Iron Sucrose, 2016–2025 (USD Million)
  • 5.4. Iron Dextran
    • 5.4.1. Global Intravenous Iron Drugs Market by Iron Dextran, 2016–2025 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Intravenous Iron Drugs Market by Others, 2016–2025 (USD Million)
• Chapter 6. Global Intravenous Iron Drugs Market –Application Analysis
  • 6.1. Global Intravenous Iron Drugs Market overview: By Application
    • 6.1.1. Global Intravenous Iron Drugs Market share, By Application, 2018 and 2025
  • 6.2. Cancer
    • 6.2.1. Global Intravenous Iron Drugs Market By Cancer, 2016–2025 (USD Million)
  • 6.3. Inflammatory Bowel Disease
    • 6.3.1. Global Intravenous Iron Drugs Market By Inflammatory Bowel Disease, 2016–2025 (USD Million)
  • 6.4. Chronic Kidney Disease
    • 6.4.1. Global Intravenous Iron Drugs Market By Chronic Kidney Disease, 2016–2025 (USD Million)
  • 6.5. Other Diseases
    • 6.5.1. Global Intravenous Iron Drugs Market By Other Diseases, 2016–2025 (USD Million)
• Chapter 7. Global Intravenous Iron Drugs Market - Regional Analysis
  • 7.1. Global Intravenous Iron Drugs Market overview: by Region
    • 7.1.1. Global Intravenous Iron Drugs Market share, by Region, 2018 and 2025
  • 7.2. North America
    • 7.2.1. North America Intravenous Iron Drugs Market, 2016–2025 (USD Million)
    • 7.2.2. North America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
    • 7.2.3. North America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
      • 7.2.4. U.S.
        • 7.2.4.1. U.S. Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
        • 7.2.4.2. U.S. Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
    • 7.2.5. Rest of North America
      • 7.2.5.1. Rest of North America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
      • 7.2.5.2. Rest of North America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Intravenous Iron Drugs Market, 2016–2025 (USD Million)
    • 7.3.2. Europe Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
    • 7.3.3. Europe Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
    • 7.3.4. UK
      • 7.3.4.1. U.K. Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
      • 7.3.4.2. U.K. Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. France Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
      • 7.3.5.2. France Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
    • 7.3.6. Germany
      • 7.3.6.1. Germany Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
      • 7.3.6.2. Germany Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
    • 7.3.7. Rest of Europe
      • 7.3.7.1. Rest of Europe Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
      • 7.3.7.2. Rest of Europe Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Intravenous Iron Drugs Market, 2016–2025 (USD Million)
    • 7.4.2. Asia Pacific Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
    • 7.4.3. Asia Pacific Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. China Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
      • 7.4.4.2. China Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
    • 7.4.5. Japan
      • 7.4.5.1. Japan Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
      • 7.4.5.2. Japan Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
    • 7.4.6. India
      • 7.4.6.1. India Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
      • 7.4.6.2. India Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
    • 7.4.7. Rest of Asia Pacific
      • 7.4.7.1. Rest of Asia Pacific Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
      • 7.4.7.2. Rest of Asia Pacific Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Intravenous Iron Drugs Market, 2016–2025 (USD Million)
    • 7.5.2. Latin America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
    • 7.5.3. Latin America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
    • 7.5.4. Brazil
      • 7.5.4.1. Brazil Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
      • 7.5.4.2. Brazil Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
    • 7.5.5. Rest of Latin America
      • 7.5.5.1. Rest of Latin America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
      • 7.5.5.2. Rest of Latin America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
  • 7.6. The Middle East and Africa
    • 7.6.1. The Middle East and Africa Intravenous Iron Drugs Market, 2016–2025 (USD Million)
    • 7.6.2. The Middle East and Africa Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
    • 7.6.3. The Middle East and Africa Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
• Chapter 8. Company Profiles
  • 8.1. Daiichi Sankyo Company, Ltd.
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategy
    • 8.1.5. Recent Developments
  • 8.2. Allergan, Inc.
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategy
    • 8.2.5. Recent Developments
  • 8.3. Sanofi
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategy
    • 8.3.5. Recent Developments
  • 8.4. Rockwell Medical Technologies, Inc.
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategy
    • 8.4.5. Recent Developments
  • 8.5. Fresenius Medical Care AG & Co.
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategy
    • 8.5.5. Recent Development
  • 8.6. AMAG Pharmaceuticals. Inc.
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Portfolio
    • 8.6.4. Business Strategy
    • 8.6.5. Recent Development
  • 8.7. Pharmacosmos A/S
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product Portfolio
    • 8.7.4. Business Strategy
    • 8.7.5. Recent Development
  • 8.8. Vifor Pharma Management Ltd.
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product Portfolio
    • 8.8.4. Business Strategy
    • 8.8.5. Recent Development
  • 8.9. American Regent. Inc.
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategy
    • 8.9.5. Recent Development
  • 8.10. Shield Therapeutics Plc
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Strategy
    • 8.10.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Intravenous Iron Drugs Market, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Intravenous Iron Drugs Market attractiveness, By Product
6. Global Intravenous Iron Drugs Market attractiveness, By Application
7. Global Intravenous Iron Drugs Market attractiveness, By Region
8. Global Intravenous Iron Drugs Market share, By Product, 2018 and 2025
9. Global Intravenous Iron Drugs Market by Ferric Carboxymaltose, 2016–2025 (USD Million)
10. Global Intravenous Iron Drugs Market by Iron Sucrose,2016–2025 (USD Million)
11. Global Intravenous Iron Drugs Market by Iron Dextran,2016–2025 (USD Million)
12. Global Intravenous Iron Drugs Market by Others,2016–2025 (USD Million)
13. Global Intravenous Iron Drugs Market share, By Application, 2018 and 2025
14. Global Intravenous Iron Drugs Market By Cancer , 2016–2025 (USD Million)
15. Global Intravenous Iron Drugs Market By Inflammatory Bowel Disease, 2016–2025 (USD Million)
16. Global Intravenous Iron Drugs Market By Chronic Kidney Disease, 2016–2025 (USD Million)
17. Global Intravenous Iron Drugs Market By Other Diseases, 2016–2025 (USD Million)
18. Global Intravenous Iron Drugs Market share, by Region, 2018and 2025
19. North America Intravenous Iron Drugs Market, 2016–2025 (USD Million)
20. Europe Intravenous Iron Drugs Market, 2016–2025 (USD Million)
21. Asia Pacific Intravenous Iron Drugs Market, 2016–2025 (USD Million)
22. Latin America Intravenous Iron Drugs Market, 2016–2025 (USD Million)
23. The Middle East and Africa Intravenous Iron Drugs Market, 2016–2025 (USD Million)
 

Table Of Tables

List of Tables

1. Global Intravenous Iron Drugs Market: snapshot
2. Drivers of the Intravenous Iron Drugs Market: impact analysis
3. Restraints of the Intravenous Iron Drugs Market: impact analysis
4. North America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
5. North America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
6. U.S. Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
7. U.S. Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
8. Rest of North America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
9. Rest of North America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
10. Europe Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
11. Europe Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
12. U.K. Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
13. U.K. Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
14. France Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
15. France Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
16. Germany Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
17. Germany Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
18. Rest of Europe Intravenous Iron Drugs revenue, By Product,2016–2025 (USD Million)
19. Rest of Europe Intravenous Iron Drugs revenue, By Application, 2016–2025 (USD Million)
20. Asia Pacific Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
21. Asia Pacific Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
22. China Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
23. China Intravenous Iron Drugs revenue, By Application, 2016–2025 (USD Million)
24. Japan Intravenous Iron Drugs revenue, By Product,2016–2025 (USD Million)
25. Japan Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
26. India Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
27. India Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
28. Rest of Asia Pacific Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
29. Rest of Asia Pacific Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
30. Latin America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
31. Latin America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
32. Brazil Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
33. Brazil Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
34. Rest of Latin America Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
35. Rest of Latin America Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)
36. The Middle East and Africa Intravenous Iron Drugs Market revenue, By Product,2016–2025 (USD Million)
37. The Middle East and Africa Intravenous Iron Drugs Market revenue, By Application, 2016–2025 (USD Million)